| |
|
|
|
BioCryst Pharmaceuticals Inc.  
|
|
2.91 -0.23 (-0.07%) |
09-17 16:00 |
|
Open: |
3.14 |
Pre close: |
3.14 |
Target:
|
3.54 
|
|
High: |
3.145 |
Low: |
2.835 |
Resistance:
|
3.03
3.36
|
|
Volume: |
2,324,552 |
Market Cap: |
321M |
Support:
|
2.49
2.07
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.11
|
MACD |
MACD(12,26):
|
0.03 |
|
MA(20): |
2.96  |
Signal(12,26,9): |
0.01 |
|
MA(100): |
4.00 |
Stochastic Oscillator |
%K(14,3):
|
59.32 |
|
MA(250): |
6.49 |
%D(3): |
70.19 |
|
Average Volume(K) |
3-Month: |
133977
|
52-Week |
High:
|
9.95 |
|
10-Days: |
132461 |
Low: |
2.49 |
|
RSI |
RSI(14):
|
45.10 |
Change(%): |
-59.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.154 |
Return on Equity (ttm) |
-679.7 |
Shares Out. (M) |
110.44 |
|
EPS Est. Current Year |
-0.750 |
Return on Assets (ttm) |
-52.9 |
Shares Float (M) |
75.68 |
|
EPS Est. Next Year |
-0.780 |
PEG Ratio |
-0.13 |
% Held by Insiders |
1.04 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
-88.4 |
% Held by Institutions |
93.64 |
|
Forward EPS |
-0.900 |
Gross Profit (p.s.) |
-0.586 |
Shares Short (K) |
13260 |
|
Book Value (p.s.) |
-0.080 |
EBITDA (p.s.) |
-0.962 |
P/E |
-2.52 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-36.38 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-110.52 |
P/S |
2921640192.00 |
|
Operating Margin |
-929.01 |
Levered Free Cash Flow
(M) |
-56.04 |
P/CF |
-2.91 |
|
|
|
|
|
|
